has been responsible for marketing development of the Diabetes Business at Boehringer Mannheim (Roche) for over 15 years. Later as consultant and interim manager, he realized business development opportunities for various Pharma, Diagnostics and Medical Device companies. This included preclinical and clinical development, market launch and reimbursement in different health care systems. He always aims to realize and develop markets ideally together with customers for customers and was able to build a strong international business network. As QRSKIN’s CEO, his focus is the development of new wound care dressings for a far better treatments of severe burns and wounds. Franz has a Diplom (Master) in Chemistry and a Diplom Business from both Universities in Munich.
joined the company as Chief Operating Officer in 2014. Martin Funk, previously CEO of DiaCoating GmbH and Managing Director of CMFBio Consulting, possesses 20 years of experience in the biotechnology industry. He holds a PhD in molecular biology and worked several years for MediGene AG as Vice President of Project Management. Previous to joining QRSKIN, he headed the GMP production unit for ATMPs at the Fraunhofer IGB in Stuttgart.
joined the company as Director Sales in 2018. Max dedicated more than 12 years of his professional career to innovative medical devices sales activities, more than 10 of these as member of the board of directors of his employers. He traveled the whole world to support the availability of top medical products in all regions worldwide and has 7 years of focused experience in marketing and sales of innovative burn treatments, like Suprathel. Thus he gained very profound experience and expertise in this sector, having the privilege to support many doctors, hospitals and organizations in providing best possible help for the victims of fire, explosions and accidents. Max holds a state examination in medicine of the University of Lübeck.